European Commission logo
English English
CORDIS - EU research results
CORDIS

Evaluating the Long-Run Socioeconomic Effects of Childhood Vaccination

Project description

Long-term effects of vaccination

In 1954, the enormous trial of Salk polio vaccine was conducted, involving 1.8 million children aged 6-10 years. The study was concentrated on proving the direct benefits for herd immunity only. No further investigation used such a huge data set to investigate the economic long-standing outcomes of the mass vaccination for economic well-being. Yet, this could bring forth strong arguments for advocating vaccination for society’s broader future welfare. The EU-funded Valvax project will study the Salk trials’ data to explain the long-term social benefits. These include changes to household consumption, or investment behaviour that can be attributed to early childhood experience with vaccines.

Objective

This MSCA research project “Evaluating the Long-Run Socioeconomic Effects of Childhood Vaccination” (Valvax) combines research in the fields of economics and clinical sciences to ask the overarching research question: What are the long-run social benefits attributable to early childhood access and experience with vaccines? To answer this question, I will use the historical 1954 Salk polio vaccine trial and detailed individual level microdata to study the socio-effects of childhood vaccination. With over 1.8 million child participants ages 6-10, the Salk trials were one of the largest medical trials ever conducted. While the direct benefits of herd immunity and reductions in infectious disease are well studied, researchers have not studied the potential long-run effects of increased vaccine coverage on socioeconomic outcomes. Furthermore, economic historians have not studied the Salk trial and its effects. Economists have established a strong connection between early childhood health and measures of economic wellbeing later in adulthood. Furthermore, medical researchers have found that vaccines can broadly affect overall health. Valvax combines the University of Southern Denmark’s research expertise on the indirect effects of vaccines and focus in economic history to analyze the Salk trials and provide the first-ever study on the long-run socioeconomic effects of childhood vaccinations.

Coordinator

SYDDANSK UNIVERSITET
Net EU contribution
€ 207 312,00
Address
CAMPUSVEJ 55
5230 Odense M
Denmark

See on map

Region
Danmark Syddanmark Fyn
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 207 312,00